Ahmet Kemal Filiz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahmet Kemal Filiz has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Sebahattin Karabulut
Sivas Cumhuriyet Üniversitesi
3 shared publications - Fatih Yulak
Cumhuriyet Üniversitesi
2 shared publications - Arzuhan Çeti̇nDağ Çi̇lTaş
Sivas cumhuriyet üniversitesi, Sağlık Hizmetleri Meslek Yüksekokulu
1 shared publication - Ayşegül Öztürk
Sivas Cumhuriyet Üniversitesi
1 shared publication - Mehtap Şahin
Sivas Cumhuriyet Üniversitesi
1 shared publication - Recep Akkaya
Cumhuriyet University, Vocational School of Health Services, 58140 Sivas, Turkey
1 shared publication
Latest Publications
- Open Access
- 27 September 2026
- Published by Kastamonu University in Kastamonu Medical Journal
- Vol. 6 (3) , 254-262
Galium aparine L. extract inhibits the proliferation of HT-29 cells and induces apoptosis
Aims: Galium Aparine L. (G. aparine) has been traditionally used as a medicinal herb for the treatment of cancer, fever, hypertension. This study aimed to evaluate the potential anticancer effects of G. aparine in HT-29 colon cancer cells and to investigate the molecular mechanisms that may be involved in these effects.Methods: The LC/Q-TOF/MS analysis was employed to conduct a qualitative phytochemical characterization of G. aparine. To evaluate the potential anticolorectal cancer effects of G. aparine, HT-29 cells were pretreated with G. aparine. Then, cell viability was examined by XTT assay, cell cycle distribution by flow cytometry and cell death by annexin V assay. In addition, the effect of G. aparine treatment on epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase- 1 (ERK-1), ERK-2, and apoptotic markers caspase-3 and Bcl-2-associated agonist of cell death (BAD) levels were investigated by ELISA method.Results: Following treatment with G. aparine, HT-29 cells exhibit increased apoptosis and cell cycle inhibition at the G0/G1 phase, as evidenced by the Annexin V binding assay (p<0.05). Moreever, G. aparine treatment significantly decreased EGFR and ERK-1 levels (p0.05). The apoptotic impact of G. aparine was additionally verified through ELISA assays evaluating the levels of BAD and caspase 3 (p<0.05).Conclusion: Taken together, the results demonstrate that G. aparine extract exerts significant anti-colorectal cancer effects by promoting apoptosis and inhibiting EGFR/ERK signaling.
- 27 September 2026
- Published by Kastamonu University in Kastamonu Medical Journal
- Vol. 6 (3) , 254-262
Open AccessGalium aparine L. extract inhibits the proliferation of HT-29 cells and induces apoptosis
Aims: Galium Aparine L. (G. aparine) has been traditionally used as a medicinal herb for the treatment of cancer, fever, hypertension. This study aimed to evaluate the potential anticancer effects of G. aparine in HT-29 colon cancer cells and to investigate the molecular mechanisms that may be involved in these effects.Methods: The LC/Q-TOF/MS analysis was employed to conduct a qualitative phytochemical characterization of G. aparine. To evaluate the potential anticolorectal cancer effects of G. aparine, HT-29 cells were pretreated with G. aparine. Then, cell viability was examined by XTT assay, cell cycle distribution by flow cytometry and cell death by annexin V assay. In addition, the effect of G. aparine treatment on epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase- 1 (ERK-1), ERK-2, and apoptotic markers caspase-3 and Bcl-2-associated agonist of cell death (BAD) levels were investigated by ELISA method.Results: Following treatment with G. aparine, HT-29 cells exhibit increased apoptosis and cell cycle inhibition at the G0/G1 phase, as evidenced by the Annexin V binding assay (p<0.05). Moreever, G. aparine treatment significantly decreased EGFR and ERK-1 levels (p0.05). The apoptotic impact of G. aparine was additionally verified through ELISA assays evaluating the levels of BAD and caspase 3 (p<0.05).Conclusion: Taken together, the results demonstrate that G. aparine extract exerts significant anti-colorectal cancer effects by promoting apoptosis and inhibiting EGFR/ERK signaling.
- Open Access
- 23 June 2024
- Published by Cumhuriyet University in Cumhuriyet Medical Journal
- Vol. 46 (2) , 136-142
ANALYSING OF THE EFFECTS OF AN INTERLEUKIN – 1 RECEPTOR ANTAGONIST AND A RNA POLYMERASE INHIBITOR ON NEURODEGENERATION IN THE HIPPOCAMPAL CELL LINE
Objective: Glutamate is the principal excitatory neurotransmitter in the central nervous system involved in various neurophysiological functions. Both in infectious and non-infectious conditions, excessive extracellular cerebral glutamate-induced excitotoxicity is known to be triggered. Disruption of its homeostasis can be detrimental to neurons and ultimately leads to cell death. This pathological process, known as excitotoxicity, can induce neuronal cell degeneration following the overstimulation of glutamate on specific ionotropic receptors. Activation of these receptors results in neural calcium influx, which can mediate excitotoxicity through a cascade of events, including free radical production, mitochondrial dysfunction, and activation of various enzymes involved in normal cell development and function, leading to damage to the cell membrane, cytoskeleton, and DNA. Due to their heightened sensitivity to glutamate, the hippocampal HT22 cell line is utilized for modeling neurodegenerative diseases. Anakinra, an interleukin-1 receptor antagonist, is used for preventing inflammation in many autoinflammatory diseases. The aim of the present study is to investigate the anti-inflammatory and/or anti-neurodegenerative effects of favipiravir, a RNA polymerase inhibitor, and anakinra, an interleukin-1 receptor antagonist, on glutamate-induced cytotoxicity. To this end, the HT22 cell line was employed, and cell cultures were maintained under appropriate conditions. Methods: Five groups of cells were established to examine the effects of anakinra and favipiravir on glutamate-induced cytotoxicity. The control group received no treatment. The group induced with glutamate received 10 mM of glutamate for 24 hours. The anakinra group was exposed to different concentrations (1, 10, 25, 50, and 100 µg) of anakinra for 24 hours. The favipiravir group was exposed to different concentrations (1, 10, 25, 50, and 100 µg) of favipiravir for 24 hours. The anakinra+glutamate group was pre-treated with anakinra at various concentrations (1, 10, 25, 50, and 100 µg) for 1 hour and then exposed to 10 mM of glutamate for 24 hours. The favipiravir+glutamate group was pre-treated with favipiravir at various concentrations (1, 10, 25, 50, and 100 µg) for 1 hour and then exposed to 10 mM of glutamate for 24 hours. Effective doses were subsequently determined, and combinations of anakinra+favipiravir+glutamate were applied. Cell viability was assessed using the XTT test. Results: The results indicated that favipiravir did not have any effects on cell viability after glutamate application in the HT22 cell line. Viability was not affected by the application of different doses of favipiravir alone (p < 0.01 compared to the control group). When examining the effect of anakinra on cell viability after glutamate application in the HT22 cell line, it was observed that the group treated with 100 µg anakinra showed higher viability compared to other groups (p < 0.01 compared to glutamate). Viability was not affected by the application of different doses of anakinra alone (p< 0.01 compared to the control group). However, anakinra was observed to prevent the cytotoxicity induced by glutamate in the HT22 cell line when applied at 100 µg, exhibiting a protective effect against neurodegeneration at this dose. In the group where anakinra and favipiravir were combined and applied with glutamate, anakinra showed a protective effect against glutamate toxicity, but the combination of anakinra and favipiravir did not alter this effect. Conclusion: More extensive animal and human studies are required to determine the clinical implications of these findings.
- 23 June 2024
- Published by Cumhuriyet University in Cumhuriyet Medical Journal
- Vol. 46 (2) , 136-142
Open AccessANALYSING OF THE EFFECTS OF AN INTERLEUKIN – 1 RECEPTOR ANTAGONIST AND A RNA POLYMERASE INHIBITOR ON NEURODEGENERATION IN THE HIPPOCAMPAL CELL LINE
Objective: Glutamate is the principal excitatory neurotransmitter in the central nervous system involved in various neurophysiological functions. Both in infectious and non-infectious conditions, excessive extracellular cerebral glutamate-induced excitotoxicity is known to be triggered. Disruption of its homeostasis can be detrimental to neurons and ultimately leads to cell death. This pathological process, known as excitotoxicity, can induce neuronal cell degeneration following the overstimulation of glutamate on specific ionotropic receptors. Activation of these receptors results in neural calcium influx, which can mediate excitotoxicity through a cascade of events, including free radical production, mitochondrial dysfunction, and activation of various enzymes involved in normal cell development and function, leading to damage to the cell membrane, cytoskeleton, and DNA. Due to their heightened sensitivity to glutamate, the hippocampal HT22 cell line is utilized for modeling neurodegenerative diseases. Anakinra, an interleukin-1 receptor antagonist, is used for preventing inflammation in many autoinflammatory diseases. The aim of the present study is to investigate the anti-inflammatory and/or anti-neurodegenerative effects of favipiravir, a RNA polymerase inhibitor, and anakinra, an interleukin-1 receptor antagonist, on glutamate-induced cytotoxicity. To this end, the HT22 cell line was employed, and cell cultures were maintained under appropriate conditions. Methods: Five groups of cells were established to examine the effects of anakinra and favipiravir on glutamate-induced cytotoxicity. The control group received no treatment. The group induced with glutamate received 10 mM of glutamate for 24 hours. The anakinra group was exposed to different concentrations (1, 10, 25, 50, and 100 µg) of anakinra for 24 hours. The favipiravir group was exposed to different concentrations (1, 10, 25, 50, and 100 µg) of favipiravir for 24 hours. The anakinra+glutamate group was pre-treated with anakinra at various concentrations (1, 10, 25, 50, and 100 µg) for 1 hour and then exposed to 10 mM of glutamate for 24 hours. The favipiravir+glutamate group was pre-treated with favipiravir at various concentrations (1, 10, 25, 50, and 100 µg) for 1 hour and then exposed to 10 mM of glutamate for 24 hours. Effective doses were subsequently determined, and combinations of anakinra+favipiravir+glutamate were applied. Cell viability was assessed using the XTT test. Results: The results indicated that favipiravir did not have any effects on cell viability after glutamate application in the HT22 cell line. Viability was not affected by the application of different doses of favipiravir alone (p < 0.01 compared to the control group). When examining the effect of anakinra on cell viability after glutamate application in the HT22 cell line, it was observed that the group treated with 100 µg anakinra showed higher viability compared to other groups (p < 0.01 compared to glutamate). Viability was not affected by the application of different doses of anakinra alone (p< 0.01 compared to the control group). However, anakinra was observed to prevent the cytotoxicity induced by glutamate in the HT22 cell line when applied at 100 µg, exhibiting a protective effect against neurodegeneration at this dose. In the group where anakinra and favipiravir were combined and applied with glutamate, anakinra showed a protective effect against glutamate toxicity, but the combination of anakinra and favipiravir did not alter this effect. Conclusion: More extensive animal and human studies are required to determine the clinical implications of these findings.
- 21 April 2022
- Published by Taylor & Francis in Neurological Research
- Vol. 44 (10) , 902-909
Thiamine alleviates cognitive impairment and epileptogenesis by relieving brain inflammation in PTZ-induced kindling rat model
Epileptogenesis, the process by which the brain becomes epileptic, is related to neuroinflammation, hyperexcitability cognitive deficits. Evidence suggests that improving brain inflammation can inh...
- 21 April 2022
- Published by Taylor & Francis in Neurological Research
- Vol. 44 (10) , 902-909
Thiamine alleviates cognitive impairment and epileptogenesis by relieving brain inflammation in PTZ-induced kindling rat model
Epileptogenesis, the process by which the brain becomes epileptic, is related to neuroinflammation, hyperexcitability cognitive deficits. Evidence suggests that improving brain inflammation can inh...
- Open Access
- 1 October 2021
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 16 (4) , 122-128
Mechanism of anti-cancer effect of β-glucan on SH-SY5Y cell line
Anti-cancer property of fungi derived β-glucan (Lentinula edodes) on several cancer cell lines have been reported. In this work, the SH-SY5Y cell lines were treated with various concentrations of β-glucan (62.5, 125, 250 and 500 μg/mL) and the viability of the cells was tested using the XTT assay after 24 hours. Cleaved PARP, BCL-2, 8-hydroxy-desoxyguanosine (8-oxo-dG), cleaved caspase 3, Bax, total oxidant, and total antioxidant levels in the cells were measured by commercial kits. β-Glucan significantly decreased the cell viability in SH-SY5Y cells. ELISA tests demonstrated that β-glucan therapy dramatically increased 8-oxo-dG, cleaved caspase 3, Bax, cleaved PARP, total oxidant. However, β-glucan treatment did not change the BCL-2 protein level. Altogether, β-glucan caused significant cytotoxicity in SH-SY5Y cells by inducing oxidative stress, increasing DNA damage, and ultimately increasing apoptosis.
- 1 October 2021
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 16 (4) , 122-128
Open AccessMechanism of anti-cancer effect of β-glucan on SH-SY5Y cell line
Anti-cancer property of fungi derived β-glucan (Lentinula edodes) on several cancer cell lines have been reported. In this work, the SH-SY5Y cell lines were treated with various concentrations of β-glucan (62.5, 125, 250 and 500 μg/mL) and the viability of the cells was tested using the XTT assay after 24 hours. Cleaved PARP, BCL-2, 8-hydroxy-desoxyguanosine (8-oxo-dG), cleaved caspase 3, Bax, total oxidant, and total antioxidant levels in the cells were measured by commercial kits. β-Glucan significantly decreased the cell viability in SH-SY5Y cells. ELISA tests demonstrated that β-glucan therapy dramatically increased 8-oxo-dG, cleaved caspase 3, Bax, cleaved PARP, total oxidant. However, β-glucan treatment did not change the BCL-2 protein level. Altogether, β-glucan caused significant cytotoxicity in SH-SY5Y cells by inducing oxidative stress, increasing DNA damage, and ultimately increasing apoptosis.
- 29 March 2021
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 42 (1) , 1-6
The effect of penicillin-induced epileptiform activity on proinflammatory cytokines levels in the rat brain
Emerging evidence indicates a pathogenic role of protracted neuroinflammation in the various neurodegenerative diseases, including epilepsy. Neuroinflammation may contribute to neuronal hyperexcitability underlying seizure formation. The current research aims to examine the changes in the levels of proinflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in the penicillin epilepsy model. In the present study, 12 male Wistar albino rats were randomly divided into two groups as sham and penicillin epilepsy model. Seizures were induced with the intracortical (i.c.) single microinjection 500 IU of penicillin-G into neocortex. Rats were decapitated after observing the cortical epileptic activity and brains were removed by craniotomy. Proinflammatory cytokines (TNF-α and IL-1β) were measured by using ELISA methods in the cortical and hippocampal brain regions. Penicillin significantly up-regulated the expression of IL‑1β and TNF-α in the rat cortex, but did not affect the hippocampal cytokines levels. This study is indicative of the neuroinflammatory potential of cortical penicillin administration.
- 29 March 2021
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 42 (1) , 1-6
The effect of penicillin-induced epileptiform activity on proinflammatory cytokines levels in the rat brain
Emerging evidence indicates a pathogenic role of protracted neuroinflammation in the various neurodegenerative diseases, including epilepsy. Neuroinflammation may contribute to neuronal hyperexcitability underlying seizure formation. The current research aims to examine the changes in the levels of proinflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in the penicillin epilepsy model. In the present study, 12 male Wistar albino rats were randomly divided into two groups as sham and penicillin epilepsy model. Seizures were induced with the intracortical (i.c.) single microinjection 500 IU of penicillin-G into neocortex. Rats were decapitated after observing the cortical epileptic activity and brains were removed by craniotomy. Proinflammatory cytokines (TNF-α and IL-1β) were measured by using ELISA methods in the cortical and hippocampal brain regions. Penicillin significantly up-regulated the expression of IL‑1β and TNF-α in the rat cortex, but did not affect the hippocampal cytokines levels. This study is indicative of the neuroinflammatory potential of cortical penicillin administration.